These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9734368)

  • 1. Prospects for live attenuated HIV.
    Desrosiers RC
    Nat Med; 1998 Sep; 4(9):982. PubMed ID: 9734368
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV vaccine].
    Matano T
    Nihon Rinsho; 2005 May; 63 Suppl 5():659-65. PubMed ID: 15954426
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV vaccination dilemma.
    Sabin AB
    Nature; 1993 Mar; 362(6417):212. PubMed ID: 8318105
    [No Abstract]   [Full Text] [Related]  

  • 8. Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.
    Desrosiers RC
    J Int Assoc Physicians AIDS Care; 1998 Nov; 4(11):22-3. PubMed ID: 11366120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against human immunodeficiency virus--progress and prospects.
    Letvin NL
    N Engl J Med; 1993 Nov; 329(19):1400-5. PubMed ID: 8413438
    [No Abstract]   [Full Text] [Related]  

  • 10. Primate models of AIDS vaccine development.
    Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
    AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
    [No Abstract]   [Full Text] [Related]  

  • 11. Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.
    Das AT; Zhou X; Vink M; Klaver B; Berkhout B
    Expert Rev Vaccines; 2002 Oct; 1(3):293-301. PubMed ID: 12901570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS vaccine development and challenge viruses: getting real.
    Vlasak J; Ruprecht RM
    AIDS; 2006 Nov; 20(17):2135-40. PubMed ID: 17086052
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated retrovirus vaccines and AIDS.
    Marx PA
    Science; 1995 Nov; 270(5239):1219-20; author reply 1220-2. PubMed ID: 7502054
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection.
    Xu R; Srivastava IK; Kuller L; Zarkikh I; Kraft Z; Fagrouch Z; Letvin NL; Heeney JL; Barnett SW; Stamatatos L
    Virology; 2006 Jun; 349(2):276-89. PubMed ID: 16527321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus meeting. HIV/AIDS researchers reach for high-hanging fruit.
    Cohen J
    Science; 2009 Feb; 323(5917):996-7. PubMed ID: 19229005
    [No Abstract]   [Full Text] [Related]  

  • 19. Attenuated HIV vaccine: caveats.
    Ruprecht RM; Baba TW; Liska V
    Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.